Richard Keech

Ceftobiprole Compared With Vancomycin Plus Aztreonam in the Treatment of Acute Bacterial Skin and Skin Structure Infections: Results of a Phase 3, Randomized, Double-blind Trial (TARGET)

S. Simeonov, D. Ionescu, K. Hamed, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Single-dose oritavancin versus 7-10 days of vancomycin in the treatment of gram-positive acute bacterial skin and skin structure infections: the SOLO II noninferiority study.

W. O'Riordan, G. Corey, G. Moeck, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Spinosad 0.9% in the Treatment of Scabies: Efficacy Results from Two Multicenter, Randomized, Double-Blind, Vehicle-Controlled Studies.

Julie L Aker, C. Belcher, J. Seiler, 2021, Journal of the American Academy of Dermatology.

Single Intravenous Dose of Oritavancin for Treatment of Acute Skin and Skin Structure Infections Caused by Gram-Positive Bacteria: Summary of Safety Analysis from the Phase 3 SOLO Studies

P. Altmeyer, G. Rahav, D. Zeltser, 2018, Antimicrobial Agents and Chemotherapy.